Levobupivacaine versus Levobupivacaine-Dexmedetomidine in Thoracic Paravertebral Block for Laparoscopic Sympathectomy.
Autor: | Adel Elmaddawy AE; Department of Anesthesia, Surgical Intensive Care, Faculty of Medicine, Mansoura University, Mansoura, Egypt., Diab DG; Department of Anesthesia, Surgical Intensive Care, Faculty of Medicine, Mansoura University, Mansoura, Egypt., Farag MA; Department of Vascular Surgery, Faculty of Medicine, Mansoura University, Mansoura, Egypt. |
---|---|
Jazyk: | angličtina |
Zdroj: | Anesthesia, essays and researches [Anesth Essays Res] 2018 Oct-Dec; Vol. 12 (4), pp. 837-842. |
DOI: | 10.4103/aer.AER_126_18 |
Abstrakt: | Background: Thoracic paravertebral block (TPVB) is a high-quality analgesic technique used for many types of surgery, trauma, and chronic pain. Aim: The aim of this study is to assess safety and efficacy of adding dexmedetomidine to levobupivacaine in TPVB for postoperative analgesia after unilateral laparoscopic thoracic sympathectomy. Patients and Methods: Sixty adult patients of the American Society of Anesthesiologists physical status classes I and II, aged 20-45 years, of either sex, submitted for unilateral laparoscopic thoracic sympathectomy under general anesthesia at Mansoura University Hospital. Patients were classified into two groups such as levobupivacaine (G Statistical Analysis: Data were first tested for normality by Kolmogorov-Smirnov test. Normally distributed continuous data were analyzed using unpaired Student's t -test. Nonnormally distributed continuous and ordinal data were analyzed using Mann-Whitney U-test. Categorical data were analyzed by Chi-square test or Fisher's exact test as appropriate. Results: A faster onset and longer duration of sensory blockade was significantly higher in group G Conclusion: The addition of dexmedetomidine as adjuvant to levobupivacaine in TPVB for elective unilateral laparoscopic thoracic sympathectomy can markedly improve the postoperative analgesia with lower pain scores and a marked reduction of the postoperative analgesic requirements and low side effect profile. Competing Interests: There are no conflicts of interest. |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |